BerGenBio ASA
BerGenBio ASA (BRRGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BRRGF · as of Jun 9, 2026
Key Statistics
Explore BerGenBio ASA Data
brrgf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
brrgf competitorsBRRGF
DOGP
FTHWF
GHSI
IPCIF
IVITFStock Performance
Full HistoryAbout BerGenBio ASA
BerGenBio ASA is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapies for challenging conditions. This includes cancers that are immune-evasive, drug-resistant, or …
what is bergenbio asa · brrgf stock overview · bergenbio asa company profile · who is bergenbio asa ceo · brrgf OTC · bergenbio asa headquarters · bergenbio asa business segments
About Stock Overview & Key Data
BerGenBio ASA (BRRGF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 23, 2018. As of the latest trading session, BRRGF stock price is $97.09, with a market capitalization of $9.5B. The stock has returned -61.16% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for BerGenBio ASA stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, BerGenBio ASA reported revenue of $23.0M and net income of -$155.0M. For detailed data — including BerGenBio ASA revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BerGenBio ASA (BRRGF) stock price is $97.09. The stock is traded on OTC under the ticker symbol BRRGF. The 52-week range is $0.03 – $97.09.